Recent progress in non-clear cell renal cell carcinoma: biology and therapeutic strategies
Non-clear cell renal cell carcinomas (nccRCC) comprise a heterogeneous group of rare malignancies, accounting for approximately 20% of all kidney cancers. Given the rarity of these diverse subsets of RCC, the treatment paradigm for nccRCC is often based on treatment strategies utilized in the manage...
Saved in:
| Main Authors: | Ahmet Yildirim, Marcus W. Moses, Margo Gerke, Yash Jani, Jillian C. Thompson, Umut Akova, Mehmet A. Bilen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-06-01
|
| Series: | Therapeutic Advances in Medical Oncology |
| Online Access: | https://doi.org/10.1177/17588359251345722 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spectrum of VHL mutations in clear cell renal cell carcinoma
by: N. N. Mazurenko, et al.
Published: (2020-11-01) -
Disulfidptosis, a novel regulated cell death to predict survival and therapeutic response in kidney renal clear cell carcinoma
by: Xiaofen Wen, et al.
Published: (2025-04-01) -
Atypical Cutaneous Metastasis in Clear Cell Renal Carcinoma
by: Amanda do Carmo Gusmão, et al.
Published: (2025-07-01) -
Proteogenomics identifies c-Met inhibition as a therapeutic strategy for BAP1-deficient clear cell renal cell carcinoma
by: Bowen Du, et al.
Published: (2024-11-01) -
Radiogenomic correlation of hypoxia-related biomarkers in clear cell renal cell carcinoma
by: Yijun Shao, et al.
Published: (2025-06-01)